| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.0037 | 1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |